维存品牌怎么样 申请店铺

我要投票 维存在叶酸行业中的票数:372 更新时间:2025-08-27
维存是哪个国家的品牌?「维存」是杏辉天力(杭州)药业有限公司旗下著名品牌。该品牌发源于台湾,由创始人王昭日在1995-06-27期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力维存品牌出海!将品牌入驻外推网,定制维存品牌推广信息,可以显著提高维存产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

维存怎么样

杏辉天力(杭州)药业有限公司隶属于台湾上市公司杏辉医药集团,是杏辉集团较大的境外投资。2001年在杏辉董事会,“ 布局全球, 跨足国际, 发展全球策略及远景 “ 之指导方针下,杏辉天力药业创建于浙江省杭州市余杭区。初期厂址位于杭州市老余杭,后配合政府规划,搬迁至杭州市临平城区余杭经济开发区现址。

杏辉天力药业目前主业在天然植物提取物,植物营养素,有机种植规划、农场管理及中草药。乃一以研发为导向之创新型公司。拥有多项国内外产品专利,员工约170人。生产设备为一现代化药品级GMP,及ISO认证之自动化专业工厂。 厂房距临平中心约2公里,东邻新颜港,西邻红丰路,南靠北沙路,交通便利,水、电、汽、排污等配套设施齐全,占地面积为79亩。因应业务不断成长,公司于2017年完成新现代化植提多功能厂房三座,将成为大中华区生技业界具市场竞争力之生产基地。

杏辉天力旗下并拥有一个位于新疆于田县之大型有机种植基地及其所属公司,和田天力沙生药物开发有限责任公司,专司药材供给及种植。核心工作团队整合种植、 研发、 临床、法规、 制造、专利、商务、及相关供应炼等。

杏辉天力药业其它的生产经营范围尚有:生产西药、中成药、原料药;并开发和生产保健品。剂型含盖药品液体、胶囊、胶衣锭、颗粒、粉剂等多项。公司设有严格的品管制度,并按照G.M.P.的要求生产并提供给消费者放心之产品。 杏辉天力药业为杭州市余杭区重点骨干企业。公司将本着一贯〝诚信、务实、创新〞的企业精神,为客户及终端消费者提供良好的服务及高质量的产品.

专业及服务

杏辉天力药业团队实力坚强,拥有各类植化、植提、药学、医学、中西药品、保健食品、食品、营养、国贸、市场营销等人才。博、硕士及大学本科以上专业人员占公司所有人力约50%以上。提供之专业服务以满足客户需求为导向,有效结合种植、研发、临床、法规、制造、专利、及相关供应炼成本会计及业务等面向,有效整合及执行工作。


Xinghui Tianli (Hangzhou) Pharmaceutical Co., Ltd. belongs to Xinghui Pharmaceutical Group, a listed company in Taiwan, which is a large overseas investment of Xinghui group. In 2001, Xinghui Tianli Pharmaceutical Co., Ltd. was founded in Yuhang District, Hangzhou City, Zhejiang Province, under the guidance of the board of directors of Xinghui, "global layout, cross international development, global strategy and vision". The initial site is located in old Yuhang, Hangzhou, and then moved to the current site of Yuhang Economic Development Zone, Linping City, Hangzhou, in cooperation with the government planning. At present, Xinghui Tianli pharmaceutical is mainly engaged in natural plant extracts, plant nutrients, organic planting planning, farm management and Chinese herbal medicine. Is a R & D-oriented innovation company. With a number of domestic and foreign product patents, about 170 employees. The production equipment is a modern GMP and ISO certified automation factory. The plant is about 2km away from Linping center, adjacent to xinyangang in the East, Hongfeng road in the west, Beisha road in the south, with convenient transportation, complete water, electricity, gas, sewage and other supporting facilities, covering an area of 79mu. In response to the continuous growth of business, the company completed three new modern multi-functional plants in 2017, which will become a production base with market competitiveness in the biotechnology industry in Greater China. Xinghui Tianli owns a large-scale organic planting base and its affiliated company located in Yutian County, Xinjiang, and Hotan Tianli ShaSheng Pharmaceutical Development Co., Ltd., which specializes in the supply and planting of medicinal materials. The core team integrates planting, R & D, clinical, regulatory, manufacturing, patent, business, and related supply chain. Other production and business scope of Xinghui Tianli Pharmaceutical Co., Ltd. include: production of Western medicine, Chinese patent medicine and API; and development and production of health products. The dosage form includes liquid, capsule, gel coated ingot, granule, powder, etc. The company has strict quality control system, and according to the requirements of g.m.p. to produce and provide consumers with products at ease. Xinghui Tianli pharmaceutical is a key backbone enterprise in Yuhang District, Hangzhou. The company will, in line with the enterprise spirit of "integrity, pragmatism and innovation", provide customers and end consumers with good services and high-quality products. The professional and service team of Xinghui Tianli pharmaceutical industry is strong, with all kinds of talents in planting, planting, medicine, medicine, Chinese and Western medicine, health food, food, nutrition, international trade, marketing, etc. More than 50% of the company's personnel are professionals with bachelor's degree, master's degree and above. The professional services provided are oriented to meet the needs of customers, and effectively integrate and implement the work in combination with planting, R & D, clinical, regulatory, manufacturing, patent, and related supply refining cost accounting and business.

本文链接: https://brand.waitui.com/019c01f13.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

重仓股名单浮现,多家上市公司二季度获券商增持

当下市场进入上市公司2025年半年报密集披露期,越来越多上市公司半年报中浮现券商机构的身影。Wind数据显示,截至8月26日发稿,A股已有149家公司十大流通股东中出现券商身影,32家公司二季度获其券商大股东增持。二季度券商新进为81家上市公司十大流通股东,一定程度上体现出券商对其投资价值的认同。从券商二季度增持的重仓股行业分布情况看,不少标的来自化工、有色金属、机械设备等行业;从投资角度出发,化工行业白马股、黄金、工程机械等方向获得券商看好。(中证网)

47分钟前

国金证券:中国创新药全面收获,迈向全球舞台

36氪获悉,国金证券研报表示,中国创新药全面收获,ADC、双/多抗技术领先,管线数量全球第一。2023年License out首超License in,金额屡破纪录,海外MNC重金抢购。全球专利悬崖、技术迭代、头对头优效数据共振,肿瘤、自身免疫、减重等赛道国产新药加速出海。集采出清,政策审评、医保、商保全链条支持,业绩边际改善。

47分钟前

债市震幅加大,固收基金经理激辩布局时点

近期股债跷跷板效应再现,债券市场在8月经历了一轮显著调整,不少中长期纯债基金净值承压。展望后市,业内人士表示,从流动性角度来说,人民银行始终表态将维持适度宽松的货币政策,保持流动性充裕。8月以来,面对债券收益率调整,人民银行增量续作买断式逆回购和MLF,显示出对市场流动性的呵护。当前大幅收紧流动性的概率较小,债券收益率大幅上行的概率不大。(中证网)

47分钟前

国金证券:继续重点看好AI算力硬件

36氪获悉,国金证券研报表示,DeepSeek V3.1发布,国产算力迎新机。海外降息预期强化,英伟达、博通季报临近,ASIC需求超预期。GB200/300、B200/300加速出货,谷歌、亚马逊、Meta 2026年ASIC或超700万颗。AI-PCB、覆铜板、钻针、钻孔机、光刻设备全链满产涨价,M8-M9升级价值量倍增,大陆龙头扩产受益。继续看好AI算力硬件、苹果链及自主可控。

47分钟前

美联储降息预期升温,龙头商品有望借势上涨

在美联储主席鲍威尔释放“鸽派”信号后,市场对9月降息预期急剧升温,金融市场迅速作出反应。与此同时,大宗商品市场也因降息预期而备受关注。业内人士表示,从美联储利率路径对商品价格的传导逻辑来看,不同商品因其自身属性不同,对利率变动的反应存在显著差异。在美联储降息预期升温的背景下,那些对美联储政策比较敏感的大宗商品,如铜、白银、黄金等价格有望上涨。(中证网)

47分钟前

本页详细列出关于维存的品牌信息,含品牌所属公司介绍,维存所处行业的品牌地位及优势。
咨询